Estriol (E3) Test · Dried Urine

Estriol is the estrogen your body floods with during pregnancy. Outside pregnancy, levels stay low, but they tell you something specific: how a developing placenta is functioning, whether a fetus is in distress, and how much estrogen a postmenopausal woman is absorbing from a vaginal estrogen product.

This is not a screening test for the general adult. It is a focused tool with a few high-value uses: tracking high-risk pregnancies, flagging women at higher risk of preterm birth, evaluating fetal conditions during prenatal screening, and confirming that low-dose vaginal estrogen therapy stays where it is supposed to stay.

What Estriol Actually Is

Estriol, often written as E3 (the abbreviation chemists use for the third major estrogen), is one of four natural estrogens in humans. Unlike estradiol (E2) and estrone (E1), estriol is a dead-end metabolite, meaning it cannot be converted back into the stronger estrogens. It binds estrogen receptors about 10 times less tightly than estradiol and clears the body in about 9 to 10 hours.

Most of your daily estriol production outside pregnancy is in the tens of micrograms (a microgram is one millionth of a gram). During pregnancy, the picture changes completely. The placenta and fetus work together to produce huge quantities of estriol, which is why pregnancy is the setting where this hormone matters most.

High-Risk Pregnancy Monitoring

In late pregnancy, estriol reflects how well the placenta and fetus are working together. A drop in estriol can signal trouble. In a study of 321 high-risk pregnancies, low plasma unconjugated estriol (at or below 4 ng/mL) tracked with low Apgar scores at birth and other neonatal problems, particularly when the mother had chronic high blood pressure or the fetus was not growing well.

Estriol is rarely interpreted alone. A sudden, sharp drop in serum estriol has been shown to correlate with abnormal fetal heart rate patterns, outperforming urinary estriol for detecting a fetus in trouble. Even so, a single low value is not always ominous, which is why this number is always read alongside ultrasound, fetal heart rate monitoring, and the clinical picture.

Preterm Birth Risk

Estriol can also flag elevated risk of preterm labor in women who feel completely fine. In a study of 956 singleton pregnancies, weekly salivary estriol testing starting at 22 weeks showed that a single positive reading (at or above 2.1 ng/mL) was associated with a roughly 3 to 4 times higher relative risk of spontaneous preterm labor or birth in both low-risk and high-risk women.

Two consecutive positive readings raised the test's specificity (the share of unaffected women correctly identified as not at risk) and improved the positive predictive value, at the cost of catching slightly fewer cases. In women already having symptoms of preterm labor, elevated salivary estriol also helped identify those most likely to deliver within two weeks.

Prenatal Screening for Genetic Conditions

In the second trimester, unconjugated estriol (uE3) is part of the triple and quadruple screening tests for fetal aneuploidy, the umbrella term for having too many or too few chromosomes. Low uE3 is one of the markers used in risk calculations for Down syndrome and trisomy 18 (an extra copy of chromosome 18).

Extremely low or undetectable uE3 has additional implications. It has been linked to placental steroid sulfatase deficiency and X-linked ichthyosis (a skin disorder), Smith-Lemli-Opitz syndrome (a rare cholesterol metabolism disorder), undetected intrauterine fetal death, and rare conditions like isolated adrenocorticotropic hormone deficiency in the newborn. A very low uE3 result is a signal to investigate, not a diagnosis on its own.

Diagnostic performance for Down syndrome screening was studied in 1,711 women using a panel of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and uE3 alongside maternal age. Adding hCG and uE3 to age-based screening increased the positive predictive value by 50% to 300%, depending on maternal age. In a prospective study of 9,530 women under age 35, the same combination detected fetal Down syndrome with 57% sensitivity (correctly catching 57 out of every 100 affected pregnancies) at a 3.2% amniocentesis rate.

Vaginal Estriol Therapy and Systemic Safety

Outside pregnancy, the most common reason to measure estriol is to confirm that a low-dose vaginal estrogen product is staying local. Vaginal estriol at doses of 0.005 to 0.5 mg is used for genitourinary syndrome of menopause (GSM), the umbrella term for vaginal dryness, irritation, urinary symptoms, and tissue thinning after menopause.

A systematic review of vaginal estriol use found that it produces no change or only small, transient rises in serum estriol, with estradiol and estrone unchanged and follicle-stimulating hormone (FSH) and luteinizing hormone (LH, the two pituitary hormones that signal estrogen status) staying in the postmenopausal range. This is the reason ultra-low-dose vaginal estriol is considered acceptable even in breast cancer survivors taking aromatase inhibitors (drugs that block estrogen production). Pharmacokinetic studies in this population confirm small, transient estriol increases without sustained rises in the stronger estrogens.

Reconciling Why a Lower Number Is Not Always Better or Worse

Estriol does not behave like cholesterol or blood pressure, where a clear direction is good or bad. The interpretation depends entirely on the context. In late pregnancy, a falling estriol level can signal a struggling placenta. In a postmenopausal woman using vaginal estriol cream, a stable, low serum estriol is exactly what you want to see. In second-trimester screening, a low uE3 might point to a chromosomal or metabolic condition. The number itself is neutral. The setting tells you what it means.

Reference Ranges

Estriol reference ranges depend heavily on the setting and assay. The cutpoints below come from published clinical studies of unconjugated estriol in specific populations. They are illustrative orientation, not universal targets. Your lab may report results in different units (such as nmol/L or pmol/L) and use different cutpoints. Compare your results within the same lab over time for the most meaningful trend.

Sources: Bashore and Westlake 1977 (plasma cutoff); Katagiri et al. 1976 (serial change threshold); Heine et al. 2000 (salivary screening threshold).

What this means for you: no single estriol number is meaningful in isolation. For most clinical uses, it is the trajectory across multiple readings, or the result in the context of other markers like AFP and hCG, that drives decisions.

When Results Can Be Misleading

Estriol has meaningful biological variation, especially within a single day. Knowing what shifts the number without changing the underlying biology helps you avoid overreacting to a single reading.

• Time of day: Small diurnal shifts of around 10% to 15% in plasma estriol occur in late pregnancy, with mild dips in late morning and afternoon. Salivary estriol does not show a clear daily pattern.
• Short-interval fluctuation: Salivary estriol readings taken 10 minutes apart varied by about 13%, readings 1 hour apart varied by about 23%, and readings 1 day apart varied by about 17%. Single readings can be misleading without context.
• Specimen type: Plasma, urine, and saliva each capture different fractions and have different variability. Salivary estriol reflects the unbound, biologically active form; serum measures total. The numbers are not interchangeable.
• Episodic spikes: Larger random fluctuations in plasma estriol often overshadow the small daily pattern, which is one reason a single value alone is rarely acted on in high-risk pregnancy monitoring.

Tracking Your Trend

For every meaningful clinical use of estriol, the trend matters more than a single number. The threshold for action in high-risk pregnancy monitoring is a drop greater than 40% to 45% from the average of three prior readings, which directly implies that at least three baseline measurements are needed before any single value can be flagged as concerning.

For preterm birth screening, weekly salivary estriol starting at 22 weeks was the protocol that showed value, and two consecutive elevated readings carried more weight than one. For women on vaginal estriol therapy, retesting at 6 to 12 weeks after starting treatment confirms that systemic exposure is staying low, and periodic checks during long-term use can catch any drift.

What to Do If Results Are Abnormal

An abnormal estriol result is a starting point, not an endpoint. The next step depends entirely on the setting in which the test was ordered.

• Low estriol in late pregnancy: repeat testing within days, combined with fetal heart rate monitoring and detailed ultrasound. A single low value can resolve on retest.
• Elevated salivary estriol before 37 weeks: repeat the test within a week. Two consecutive elevated readings are a stronger signal and warrant a discussion with your obstetrician about preterm labor surveillance.
• Very low uE3 in second-trimester screening: this is a flag, not a diagnosis. Next steps usually include detailed ultrasound and a discussion of diagnostic testing such as amniocentesis. In some cases, screening for X-linked ichthyosis or rare metabolic conditions is appropriate.
• Persistent serum estriol elevation on vaginal estriol therapy: ask your prescriber about dose, application technique, or product choice. Sustained systemic absorption is uncommon at ultra-low doses and worth investigating if seen.